Georgia Bio (GaBio) — a private, non-profit association representing pharmaceutical, biotech, and medical device companies; universities; research institutes; medical centers; government groups; and other business organizations — has teamed up with the Georgia Research Alliance (GRA), the state of Georgia, the Metro Atlanta Chamber of Commerce, and the Innovation Crescent business community in a partnership to create the Georgia Bioscience Commercialization Center (GBCC). The center will serve as a start-up catalyst and resource center for bioscience entrepreneurs in the state. Last year, a report by researchers at the Georgia Institute of Technology suggested that metro Atlanta lacked sufficient resources to sustain high-tech start-ups. (See the previous eNews post.)

GaBio and the GRA provided seed funding for the GBCC. Key elements of the center’s operations will include a faculty of bioscience executives who will offer guidance to start-up firms at no cost and a website (www.GeorgiaBCC.com) with “how-to” information and links to service providers, event notices, technology opportunities, and other resources. “The GBCC will serve as a one-stop shop for life sciences entrepreneurs in Georgia seeking the information and contacts they need to be successful,” says Laurence Downey, MD, former president and CEO of Solvay Pharmaceuticals, who serves as a primary contact for the commercialization center.

Source: Business Wire

Posted May 12th, 2010 under Tech Transfer

Write a comment